Deltec Asset Management’s Elevation Oncology ELEV Stock Holding History

Deltec Asset Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,436,363	Closed	-$527K	–	214
2025 Q2	$527K	Buy	+1,436,363	New	+$479K	0.09%	124

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Deltec Asset Management's ELEV Position: Q3 2025 in Review

Deltec Asset Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 1,436,363 shares — an estimated $527K sold.

Deltec Asset Management first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $527K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Deltec Asset Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Deltec Asset Management sold 1,436,363 Elevation Oncology shares in Q3 2025, an estimated $527K.
Deltec Asset Management first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Deltec Asset Management's Elevation Oncology position peaked at $527K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Deltec Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.